References
- Abenavoli L. & Capasso R. et al.: Gut Microbiota and Obesity: A Role for Probiotics. Nutrients, 11(11), 2690 (2019)
- Azuri J., Hammerman A., Aboalhasan E., Sluckis B., Arbel R.: Liraglutide versus semaglutide for weight reduction-a cost needed to treat analysis. Obesity Silver Spring, Md. 31(6), 1510–1513 (2023)
- Ali A.A., Velasquez M.T., Hansen C.T., Mohamed A.I., Bhathena S.J.: Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J. Nutr. Biochem. 15, 583–590 (2004)
- Al-Ishaq R.K., Koklesova L., Kubatka P., Büsselberg D.: Immunomodufngslation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer. Cancers, 14(9), 2140 (2022)
- Álvarez-Arraño V. & Martín-Peláez S.: Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients, 13(10), 3627 (2021)
- Andersson U., Bränning C., Ahrné S., Molin G., Alenfall J., Onning G., Nyman M., Holm C.: Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Beneficial microbes, 1(2), 189–196 (2010)
- Bai J., Hu Y., Bruner D.W.: Composition of gut microbiota and its association with body mass index and lifestyle factors in a cohort of 7–18 years old children from the American Gut Project. Pediatric obesity, 14(4), e12480 (2019)
- Baohong W., Mingfei Y., Longxian L., Zongxin L., Lanjuan L.: The Human Microbiota in Health and Disease, Engineering, 3(1), 71–82 (2017)
- Behjati S. & Tarpey P.S.: What is next generation sequencing?. Archives of disease in childhood. Education and practice edition, 98(6), 236–238 (2013)
- Bello Nicholas T.: Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Expert opinion on drug safety, 18(7) 549–552, (2019)
- Bervoets L., Van Hoorenbeeck K., Kortleven I., Van Noten C., Hens N., Vael C., Goossens H., Desager K. N., Vankerckhoven V.: Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut pathogens, 5(1), 10 (2013)
- Bischoff S.C. & Schweinlin A.: Obesity therapy. Clin Nutr ESPEN, 38, 9–18 (2020)
- Canny G.O. & McCormick B.A.: Bacteria in the intestine, helpful residents or enemies from within? Infection and immunity, 76(8), 3360–3373 (2008)
- Chang B.J., Park S.U., Jang Y.S., Ko S.H., Joo N.M., Kim S.I., Kim C.H., Chang D.K.: Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. European journal of clinical nutrition, 65(11), 1250–1255 (2011)
- Chassaing B., Vijay-Kumar M., Gewirtz A.T.: How diet can impact gut microbiota to promote or endanger health. Current opinion in gastroenterology, 33(6), 417–421 (2017)
- Cerdó T., García-Santos J.A., Bermúdez, M.G., Campoy C.: The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients, 11(3), 635 (2019)
- Collado M.C., Rautava S., Aakko J., Isolauri E., Salminen S.: Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Scientific reports, 6, 23129 (2016)
- D’Argenio V. and Salvatore F.: The role of the gut microbiome in the healthy adult status., Clin Chim Acta, 7(451), 97–102 (2015)
- DeGruttola A.K., Low D., Mizoguchi A., Mizoguchi E.: Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammatory bowel diseases, 22(5), 1137–1150 (2016)
- Depommier C. & Cani P.D. et al.: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature medicine, 25(7), 1096–1103 (2019)
- Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M.: Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International journal of systematic and evolutionary microbiology, 54(5), 1469–1476 (2004)
- DiBaise J.K., Zhang H., Crowell M.D., Krajmalnik-Brown R., Decker G.A., Rittmann B.E.: Gut microbiota and it’s possible relationship with obesity, Mayo Clin Proceedings, 83(4), 460–469 (2008)
- Dominianni C., Sinha R., Goedert J.J., Pei Z., Yang L., Hayes R.B., Ahn J.: Sex, body mass index, and dietary fiber intake influence the human gut microbiome. PloS one, 10(4), e0124599 (2015)
- Duong Q.A., Pittet L.F., Curtis N., Zimmermann P.: Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis. J Infect. 85(3), 213–300 (2022)
- Ejtahed H., Angoorani P., Soroush A., Atlasi R., Hasani-Ranjbar S., Mortazavian A., Larijani B.: Probiotics supplementation for the obesity management; A systematic review of animal studies and clinical trials. J. Funct. Foods, 52, 228–242 (2019)
- Everard A. & Cani P.D. et al.: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 110(22), 9066–9071 (2013)
- Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace, N.R.: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America, 104(34), 13780–13785 (2007)
- Góralska M., Majewska-Szczepanik M., Szczepanik M.: Mechanizmy immunologiczne towarzyszące otyłości i ich rola w zaburzeniach metabolizmu, Postepy Higieny i Medycyny Doświadczalnej, 69, 1384–1404, (2015)
- Hadi A., Sepandi M., Marx W., Moradi S., Parastouei K.: Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial. Complementary therapies in medicine, 47, 102216 (2019)
- Hill C. & Sanders M.E.: Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews. Gastroenterology & hepatology, 11(8), 506–514 (2014)
- Honjo H., Masuta Y., Otsuka Y., Masaki S., Minaga K., Kudo M., Watanabe T.: Analyses of cytokine gene expression and fecal microbiota in a patient with Cronkhite-Canada syndrome successfully treated with prednisolone. DEN open, 4(1), e222 (2023)
- Hur K.Y. & Myung-Shik L.: Gut Microbiota and Metabolic Disorders. Diabetes & metabolism journal, 39(3), 198–203 (2015)
- Iatcu C.O., Steen A., Covasa M.: Gut Microbiota and Complications of Type-2 Diabetes. Nutrients, 14(1), (2021)
- Jumpertz R., Le D.S., Turnbaugh P.J., Trinidad C., Bogardus C., Gordon J.I., Krakoff J.: Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 94, 58–65 (2011)
- Jung S., Lee Y.J., Kim M., Kim M., Kwak J.H., Lee J.W., Ahn J.T., Sim J.H., Lee J.H.: Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects. J. Funct. Foods, 19, 744–752 (2015)
- Kalliomäki M., Collado M.C., Salminen S., Isolauri E.: Early differences in fecal microbiota composition in children may predict overweight. The American journal of clinical nutrition, 87(3), 534–538 (2008)
- Karlsson F., Tremaroli V., Nielsen J., Bäckhed F.: Assessing the human gut microbiota in metabolic diseases. Diabetes, 62(10), 3341–3349 (2013)
- Karney A.: Microbiota and Obesity, Developmental period medicine, 21(3), 203–207 (2017)
- Kesavelu D. & Jog P.: Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 10 (2023)
- Lager C.J., Esfandiari N.H., Subauste A.R., Kraftson A.T., Brown M.B., Cassidy R.B., Nay C.K., Lockwood A.L., Varban O.A., Oral E.A.: Roux-En-Y Gastric Bypass Vs. Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss. Obesity surgery, 27,154–161 (2017)
- Lahtinen P. & Arkkila P. et al.: Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial. JAMA network open, 5(12), (2022)
- Larsen N., Vogensen F.K., van den Berg F.W., Nielsen D.S., Andreasen A.S., Pedersen B.K., Al-Soud W.A., Sørensen S.J., Hansen L.H., Jakobsen M.: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5(2), (2010)
- Leeming E.R., Johnson A.J., Spector T.D., Le Roy C.I.: Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients, 11(12), 2862 (2019)
- Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I.: Microbial ecology: human gut microbes associated with obesity. Nature, 444, 1022–1023(2006)
- Lin P.H., Howard L., Freedland S.J.: Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients, Annals of Medicine, 54(1), 1221–1225 (2022)
- Lobstein T., Brinsden H., Neveux M.: World Obesity Atlas 2022, World Obesity Federation. United Kingdom (2022).
- Luoto R., Kalliomäki M., Laitinen K., Isolauri E.: The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes. 34, 1531–1537 (2010)
- Macchione I.G., Lopetuso L.R., Ianiro G., Napoli M., Gibiino G., Rizzatti G., Petito V., Gasbarrini A., Scaldaferri F.: Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders. European review for medical and pharmacological sciences, 23(18), 8075–8083 (2019)
- Million M., Maraninchi M., Henry M., Armougom F., Richet H., Carrieri P., Valero R., Raccah D., Vialettes B., Raoult D.: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International journal of obesity, 36(6), 817–825 (2012)
- Mima K. & Baba H. et al.: The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms. Surgical oncology, 26(4), 368–376 (2017)
- Mueller N.T., Whyatt R., Hoepner L., Oberfield S., Dominguez-Bello M.G., Widen E.M., Hassoun A., Perera F., Rundle A.: Prenatal exposure to antibiotics, Cesarean section and risk of childhood obesity. Int. J. Obes. Lond. 39(4), 665–670 (2015)
- Mukhopadhya I., Segal J.P., Carding S.R., Hart A.L., Hold G.L.: The gut virome: the ‘missing link’ between gut bacteria and host immunity?. Therapeutic advances in gastroenterology, 12 (2019)
- NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet, 390, 2627–2642 (2017)
- Oren A. & Garrity G.M.: Valid publication of the names of forty-two phyla of prokaryotes. Int J Syst Evol Microbiol. 71(10), (2021)
- Panasiuk A. and Kowalinska J.: Mikrobiota przewodu pokarmowego, PZWL, Wydanie I, (2023)
- Petrov M.E. & Whisner C.M. et al.: Protocol of the Snuggle Bug/ Acurrucadito Study: a longitudinal study investigating the influences of sleep-wake patterns and gut microbiome development in infancy on rapid weight gain, an early risk factor for obesity. BMC Pediatr. 21, 374 (2021)
- Pokrzywnicka P. & Gumprecht J.: Intestinal microbiota and its relationship with diabetes and obesity. Clin Diabetol. 5, 164–172 (2016)
- Richelsen B., Tonstad S., Rössner S., Toubro S., Niskanen L., Madsbad S., Mustajoki P., Rissanen A.: Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes care 30(1), 27–32 (2007)
- Ridaura V.K. & Gordon J.I. et al.: Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341(6150), 1241214 (2013)
- Rinninella E., Raoul P., Cintoni M., Franceschi F., Miggiano G.A.D., Gasbarrini A., Mele M.C.: What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7(1), 14 (2019)
- Rizzatti G., Lopetuso L.R., Gibiino G., Binda C., Gasbarrini A.: Proteobacteria: A Common Factor in Human Diseases. BioMed research international, 2017, 9351507 (2017)
- Rosen D.J., Dakin G.F., Pomp A.: Sleeve gastrectomy. Minerva chirurgica, 64(3), 285–295 (2009)
- Sarangi A.N., Goel A., Aggarwal R.: Methods for Studying Gut Microbiota: A Primer for Physicians.” Journal of clinical and experimental hepatology, 9(1), 62–73 (2019)
- Schneeberger M., Everard M., Gómez-Valadés A.G., Matamoros S., Ramírez S., Delzenne N.M., Gomis R., Claret M., Cani P.D.: Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 5, 16643 (2015)
- Sender R., Fuchs S., Milo R.: Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS biology, 14(8) (2016)
- Shanahan F. & Murphy E.: The hybrid science of diet, microbes, and metabolic health. Am. J. Clin. Nutr. 94, 1–2 (2011)
- Xiao S. & Zhao L. et al.: A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome, FEMS Microbiology Ecology, 87(2), 357–367, (2014)
- Singh S., de Moura D.T.H., Khan A., Bilal M., Chowdhry M., Ryan M. B., Bazarbashi A. N., Thompson C.C.: Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis. Obesity surgery, 30, 3010–3029 (2020)
- Smith S.M., Meyer M., Trinkley K.E.: Phentermine/topiramate for the treatment of obesity. The Annals of pharmacotherapy, 47(3), 340–349 (2013)
- Tokarz-Deptula B., Sliwa-Dominiak J., Adamiak M., Bąk K., Deptula W.: Bakterie komensalne a odpornosc ukladu pokarmowego, oddechowego i moczowo – płciowego, Postępy Higieny i Medycyny Doswiadczalnej, 70, 599–609 (2016)
- Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027–1031 (2006)
- Wadden T.A., Hollander P., Klein S., Niswender K., Woo V., Hale P.M., Aronne L., NN8022-1923 Investigators: Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International journal of obesity, 37(11), 1443–51 (2013)
- Walker A.W. & Parkhill J.: Microbiology. Fighting obesity with bacteria. Science (New York, N.Y.), 341(6150), 1069–1070 (2013)
- Wu G.D. & Lewis J.D. et al.: Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science, 334, 105–108 (2011)
- Wu G.D. & Lewis J.D. et al.: Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut, 65(1), 63–72 (2016)
- Yin Y.N., Yu Q.F., Fu N., Liu X.W., Lu F.G.: Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World journal of gastroenterology, 16(27), 3394–33401 (2010)
- Zhang X., Ha S., Cheuk-Hay Lau H., Yu J.: Excess body weight: Novel insights into its roles in obesity comorbidities. Seminars in cancer biology, 92, 16–27 (2023)
- Zhao X., Higashikawa F, Noda M., Kawamura Y., Matoba Y., Kumagai T., Sugiyama M.: The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese mice. PloS one, 7(2), e30696 (2012)
- Zhernakova A. & Fu J. et al.: Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (New York, N.Y.) 352, (6285) 565–569 (2016)
- Zhu B., Wang X., Li L.: Human gut microbiome: the second genome of human body. Protein & cell, 1(8), 718–725 (2010)